A citation-based method for searching scientific literature

John Hutchinson, Andrew Fogarty, Richard Hubbard, Tricia McKeever. Eur Respir J 2015
Times Cited: 367







List of co-cited articles
670 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
42

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
32

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
25

Idiopathic pulmonary fibrosis.
Luca Richeldi, Harold R Collard, Mark G Jones. Lancet 2017
573
24

Idiopathic Pulmonary Fibrosis.
David J Lederer, Fernando J Martinez. N Engl J Med 2018
538
22

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
21

Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
Brett Ley, Harold R Collard, Talmadge E King. Am J Respir Crit Care Med 2011
914
17

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
17

Idiopathic pulmonary fibrosis.
Fernando J Martinez, Harold R Collard, Annie Pardo, Ganesh Raghu, Luca Richeldi, Moises Selman, Jeffrey J Swigris, Hiroyuki Taniguchi, Athol U Wells. Nat Rev Dis Primers 2017
368
16

Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11.
Ganesh Raghu, Shih-Yin Chen, Wei-Shi Yeh, Brad Maroni, Qian Li, Yuan-Chi Lee, Harold R Collard. Lancet Respir Med 2014
332
13

Incidence and prevalence of idiopathic pulmonary fibrosis.
Ganesh Raghu, Derek Weycker, John Edelsberg, Williamson Z Bradford, Gerry Oster. Am J Respir Crit Care Med 2006
820
12


Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg,[...]. Lancet 2011
11

Increasing global mortality from idiopathic pulmonary fibrosis in the twenty-first century.
John P Hutchinson, Tricia M McKeever, Andrew W Fogarty, Vidya Navaratnam, Richard B Hubbard. Ann Am Thorac Soc 2014
111
9

A common MUC5B promoter polymorphism and pulmonary fibrosis.
Max A Seibold, Anastasia L Wise, Marcy C Speer, Mark P Steele, Kevin K Brown, James E Loyd, Tasha E Fingerlin, Weiming Zhang, Gunnar Gudmundsson, Steve D Groshong,[...]. N Engl J Med 2011
643
9

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
923
8

Standardized quantification of pulmonary fibrosis in histological samples.
Ralf-Harto Hübner, Wolfram Gitter, Nour Eddine El Mokhtari, Micaela Mathiak, Marcus Both, Hendrik Bolte, Sandra Freitag-Wolf, Burkhard Bewig. Biotechniques 2008
285
8

Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old.
Ganesh Raghu, Shih-Yin Chen, Qiang Hou, Wei-Shi Yeh, Harold R Collard. Eur Respir J 2016
141
8

The rising incidence of idiopathic pulmonary fibrosis in the U.K.
V Navaratnam, K M Fleming, J West, C J P Smith, R G Jenkins, A Fogarty, R B Hubbard. Thorax 2011
311
8

Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada.
Robert B Hopkins, Natasha Burke, Charlene Fell, Genevieve Dion, Martin Kolb. Eur Respir J 2016
75
10

Idiopathic pulmonary fibrosis.
Talmadge E King, Annie Pardo, Moisés Selman. Lancet 2011
8


Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study.
Evans R Fernández Pérez, Craig E Daniels, Darrell R Schroeder, Jennifer St Sauver, Thomas E Hartman, Brian J Bartholmai, Eunhee S Yi, Jay H Ryu. Chest 2010
283
7

Pathogenesis of idiopathic pulmonary fibrosis.
Paul J Wolters, Harold R Collard, Kirk D Jones. Annu Rev Pathol 2014
402
7


An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells,[...]. Am J Respir Crit Care Med 2013
6

Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.
David A Lynch, Nicola Sverzellati, William D Travis, Kevin K Brown, Thomas V Colby, Jeffrey R Galvin, Jonathan G Goldin, David M Hansell, Yoshikazu Inoue, Takeshi Johkoh,[...]. Lancet Respir Med 2018
416
6

Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span.
Alexander V Misharin, Luisa Morales-Nebreda, Paul A Reyfman, Carla M Cuda, James M Walter, Alexandra C McQuattie-Pimentel, Ching-I Chen, Kishore R Anekalla, Nikita Joshi, Kinola J N Williams,[...]. J Exp Med 2017
408
6

Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003.
Amy L Olson, Jeffrey J Swigris, Dennis C Lezotte, Jill M Norris, Carla G Wilson, Kevin K Brown. Am J Respir Crit Care Med 2007
298
6

Cellular senescence mediates fibrotic pulmonary disease.
Marissa J Schafer, Thomas A White, Koji Iijima, Andrew J Haak, Giovanni Ligresti, Elizabeth J Atkinson, Ann L Oberg, Jodie Birch, Hanna Salmonowicz, Yi Zhu,[...]. Nat Commun 2017
573
6

Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Roland M du Bois, Elizabeth A Fagan, Robert S Fishman, Ian Glaspole, Marilyn K Glassberg, Lisa Lancaster,[...]. Eur Respir J 2016
223
6

The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis.
Omkar Desai, Julia Winkler, Maksym Minasyan, Erica L Herzog. Front Med (Lausanne) 2018
106
6

Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
Imre Noth, Yingze Zhang, Shwu-Fan Ma, Carlos Flores, Mathew Barber, Yong Huang, Steven M Broderick, Michael S Wade, Pirro Hysi, Joseph Scuirba,[...]. Lancet Respir Med 2013
317
6

Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation.
Daina B Esposito, Stephan Lanes, Macarius Donneyong, Crystal N Holick, Joseph A Lasky, David Lederer, Steven D Nathan, Sean O'Quinn, Joseph Parker, Trung N Tran. Am J Respir Crit Care Med 2015
62
9

Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis.
Thanh-Thuy T Le, Harry Karmouty-Quintana, Ernestina Melicoff, Thanh-Truc T Le, Tingting Weng, Ning-Yuan Chen, Mesias Pedroza, Yang Zhou, Jonathan Davies, Kemly Philip,[...]. J Immunol 2014
157
6

Pirfenidone and nintedanib for pulmonary fibrosis in clinical practice: Tolerability and adverse drug reactions.
Jonathan A Galli, Aloknath Pandya, Michelle Vega-Olivo, Chandra Dass, Huaqing Zhao, Gerard J Criner. Respirology 2017
91
6

The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis.
Andreas Guenther, Ekaterina Krauss, Silke Tello, Jasmin Wagner, Bettina Paul, Stefan Kuhn, Olga Maurer, Sabine Heinemann, Ulrich Costabel, María Asunción Nieto Barbero,[...]. Respir Res 2018
124
6

Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry.
Helen E Jo, Ian Glaspole, Christopher Grainge, Nicole Goh, Peter M A Hopkins, Yuben Moodley, Paul N Reynolds, Sally Chapman, E Haydn Walters, Christopher Zappala,[...]. Eur Respir J 2017
111
6

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
Kevin R Flaherty, Athol U Wells, Vincent Cottin, Anand Devaraj, Simon L F Walsh, Yoshikazu Inoue, Luca Richeldi, Martin Kolb, Kay Tetzlaff, Susanne Stowasser,[...]. N Engl J Med 2019
522
6


Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy.
Sergio Harari, Fabiana Madotto, Antonella Caminati, Sara Conti, Giancarlo Cesana. PLoS One 2016
46
13

The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype.
Amy L Olson, Alex H Gifford, Naohiko Inase, Evans R Fernández Pérez, Takafumi Suda. Eur Respir Rev 2018
70
7

Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer.
Yongyu Wang, Phillip J Kuan, Chao Xing, Jennifer T Cronkhite, Fernando Torres, Randall L Rosenblatt, J Michael DiMaio, Lisa N Kinch, Nick V Grishin, Christine Kim Garcia. Am J Hum Genet 2009
298
5

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.
Luca Richeldi, Ulrich Costabel, Moises Selman, Dong Soon Kim, David M Hansell, Andrew G Nicholson, Kevin K Brown, Kevin R Flaherty, Paul W Noble, Ganesh Raghu,[...]. N Engl J Med 2011
663
5

The association between air pollution and the incidence of idiopathic pulmonary fibrosis in Northern Italy.
Sara Conti, Sergio Harari, Antonella Caminati, Antonella Zanobetti, Joel D Schwartz, Pietro A Bertazzi, Giancarlo Cesana, Fabiana Madotto. Eur Respir J 2018
56
8

Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix.
Kevin K Kim, Matthias C Kugler, Paul J Wolters, Liliane Robillard, Michael G Galvez, Alexis N Brumwell, Dean Sheppard, Harold A Chapman. Proc Natl Acad Sci U S A 2006
911
5

Developmental pathways in the pathogenesis of lung fibrosis.
Diptiman Chanda, Eva Otoupalova, Samuel R Smith, Thomas Volckaert, Stijn P De Langhe, Victor J Thannickal. Mol Aspects Med 2019
104
5

The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry.
Michael Kreuter, Jeff Swigris, David Pittrow, Silke Geier, Jens Klotsche, Antje Prasse, Hubert Wirtz, Dirk Koschel, Stefan Andreas, Martin Claussen,[...]. Respir Res 2019
42
11


The genetic basis of idiopathic pulmonary fibrosis.
Jonathan A Kropski, Timothy S Blackwell, James E Loyd. Eur Respir J 2015
95
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.